{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:15:24Z","timestamp":1707524124989},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,7,23]]},"DOI":"10.7759\/cureus.9360","type":"journal-article","created":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T19:02:32Z","timestamp":1595530952000},"source":"Crossref","is-referenced-by-count":0,"title":["Novel Use of Calcimimetic Activity to Diagnose Primary Hyperparathyroidism in a Patient With Persistently Low-Normal Parathyroid Hormone Level"],"prefix":"10.7759","author":[{"given":"Sindhura","family":"Bandaru","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sukesh","family":"Manthri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepika","family":"Nallala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaitanya K","family":"Mamillapalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael G","family":"Jakoby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2013.06.051","article-title":"The prevalence of undiagnosed and unrecognized primary hyperparathyroidism: a population-based analysis from the electronic medical record","volume":"154","author":"Press DM","year":"2013","unstructured":"Press DM, Siperstein AE, Berber E, et al.. The prevalence of undiagnosed and unrecognized primary hyperparathyroidism: a population-based analysis from the electronic medical record. Surgery. 2013, 154:1232-1238. 10.1016\/j.surg.2013.06.051","journal-title":"Surgery"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-4022","article-title":"Incidence and prevalence of primary hyperparathyroidism in a racially mixed population","volume":"98","author":"Yeh MW","year":"2013","unstructured":"Yeh MW, Ituarte PH, Zhou HC, et al.. Incidence and prevalence of primary hyperparathyroidism in a racially mixed population. J Clin Endocrinol Metab. 2013, 98:1122-1129. 10.1210\/jc.2012-4022","journal-title":"J Clin Endocrinol Metab"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31430-7","article-title":"Hyperparathyroidism","volume":"391","author":"Bilezikian JP","year":"2018","unstructured":"Bilezikian JP, Bandeira L, Khan A, Cusano NE. Hyperparathyroidism. Lancet. 2018, 391:168-178. 10.1016\/S0140-6736(17)31430-7","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/93.6.365","article-title":"Primary hyperparathyroidism with normal serum intact parathyroid hormone levels","volume":"93","author":"Mischis-Troussard C","year":"2000","unstructured":"Mischis-Troussard C, Goudet P, Verges B, Cougard P, Tavernier C, Maillefert J-F. Primary hyperparathyroidism with normal serum intact parathyroid hormone levels. QJM. 2000, 93:365-367. 10.1093\/qjmed\/93.6.365","journal-title":"QJM"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2011.09.011","article-title":"The phenotype of primary hyperparathyroidism with normal parathyroid hormone levels: how low can parathyroid hormone go?","volume":"150","author":"Wallace LB","year":"2011","unstructured":"Wallace LB, Parikh RT, Ross LV, et al.. The phenotype of primary hyperparathyroidism with normal parathyroid hormone levels: how low can parathyroid hormone go?. Surgery. 2011, 150:1102-1112. 10.1016\/j.surg.2011.09.011","journal-title":"Surgery"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-0273","article-title":"Primary hyperparathyroidism with low-normal, atypical serum parathyroid hormone as shown by discordant immunoassay curves","volume":"91","author":"Lafferty FW","year":"2006","unstructured":"Lafferty FW, Hamlin CR, Corrado KR, Arnold A, Shuck JM. Primary hyperparathyroidism with low-normal, atypical serum parathyroid hormone as shown by discordant immunoassay curves. J Clin Endocrinol Metab. 2006, 91:3826-3829. 10.1210\/jc.2006-0273","journal-title":"J Clin Endocrinol Metab"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-0247","article-title":"Primary hyperparathyroidism with low intact PTH levels in a 14-year-old girl","volume":"96","author":"Benaderet AD","year":"2011","unstructured":"Benaderet AD, Burton AM, Clifton-Bigh R, Ashraf AP. Primary hyperparathyroidism with low intact PTH levels in a 14-year-old girl. J Clin Endocrinol Metab. 2011, 96:2325-2329. 10.1210\/jc.2011-0247","journal-title":"J Clin Endocrinol Metab"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc0802570","article-title":"PTH mutation with primary hyperparathyroidism and undetectable intact PTH","volume":"359","author":"Au AYM","year":"2008","unstructured":"Au AYM, McDonald K, Gill A, Sywak M, Diamond T, Conigrave AD, Clifton-Bligh RJ. PTH mutation with primary hyperparathyroidism and undetectable intact PTH. N Engl J Med. 2008, 359:1184-1186. 10.1056\/NEJMc0802570","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2008.03225.x","article-title":"Very low or undetectable intact parathyroid hormone levels in patients with surgically verified parathyroid adenomas","volume":"69","author":"Bhadada SK","year":"2008","unstructured":"Bhadada SK, Cardenas M, Bhansali A, et al.. Very low or undetectable intact parathyroid hormone levels in patients with surgically verified parathyroid adenomas. Clin Endocrinol. 2008, 69:382-385. 10.1111\/j.1365-2265.2008.03225.x","journal-title":"Clin Endocrinol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.02470312","article-title":"Onco-nephrology: the pathophysiology and treatment of malignancy-associated hypercalcemia","volume":"7","author":"Rosner MH","year":"2012","unstructured":"Rosner MH, Dalkin AC. Onco-nephrology: the pathophysiology and treatment of malignancy-associated hypercalcemia. Clin J Am Soc Nephrol. 2012, 7:1722-1729. 10.2215\/CJN.02470312","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-021597","article-title":"The calcimimetic cinacalcet normalizes serum calcium in subjects with primary hyperparathyroidism","volume":"88","author":"Shoback DM","year":"2003","unstructured":"Shoback DM, Bilezikian JP, Turner SA, McCary LC, Guo MD, Peacock M. The calcimimetic cinacalcet normalizes serum calcium in subjects with primary hyperparathyroidism. J Clin Endocrinol Metab. 2003, 88:5644-5649. 10.1210\/jc.2002-021597","journal-title":"J Clin Endocrinol Metab"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-126-6-199703150-00003","article-title":"The rise and fall of primary hyperparathyroidism: a population-based study in Rochester, Minnesota, 1965-1992","volume":"126","author":"Wermers RA","year":"1997","unstructured":"Wermers RA, Khosla S, Atkinson EJ, Hodgson SF, O\u2019Fallon WM, Melton 3rd LJ. The rise and fall of primary hyperparathyroidism: a population-based study in Rochester, Minnesota, 1965-1992. Ann Intern Med. 1997, 126:433-440. 10.7326\/0003-4819-126-6-199703150-00003","journal-title":"Ann Intern Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/33.8.1364","article-title":"Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia","volume":"33","author":"Nussbaum SR","year":"1987","unstructured":"Nussbaum SR, Zahradnik RJ, Lavigne JR, et al.. Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia. Clin Chem. 1987, 33:1364-1367. 10.1093\/clinchem\/33.8.1364","journal-title":"Clin Chem"},{"key":"ref14","doi-asserted-by":"crossref","DOI":"10.4158\/EP.18.1.101","article-title":"A novel use of cinacalcet to distinguish primary hyperparathyroidism from hypercalcemia of malignancy in a patient with a low-normal parathyroid hormone concentration","volume":"18","author":"Zwerling HK","year":"2012","unstructured":"Zwerling HK. A novel use of cinacalcet to distinguish primary hyperparathyroidism from hypercalcemia of malignancy in a patient with a low-normal parathyroid hormone concentration. Endocr Pract. 2012, 18:101-102.","journal-title":"Endocr Pract"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-0842","article-title":"Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism","volume":"90","author":"Peacock M","year":"2005","unstructured":"Peacock M, Bilezikian JP, Klassen PS, Guo MD, Turner SA, Shoback D. Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism. J Clin Endocrinol Metab. 2005, 90:135-141. 10.1210\/jc.2004-0842","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/35683-novel-use-of-calcimimetic-activity-to-diagnose-primary-hyperparathyroidism-in-a-patient-with-persistently-low-normal-parathyroid-hormone-level","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:19:59Z","timestamp":1707506399000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/35683-novel-use-of-calcimimetic-activity-to-diagnose-primary-hyperparathyroidism-in-a-patient-with-persistently-low-normal-parathyroid-hormone-level"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,23]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.9360","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7,23]]}}}